PATENT CLAIM ANALYSIS

Application Number: 15972277
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to a recombinant avian herpes virus, which comprises at least two recombinant nucleotide sequences, each recombinant nucleotide sequence encoding a distinct antigenic peptide, wherein the at least two recombinant nucleotide sequences are inserted into distinct non-coding regions of the viral genome chosen among the region located between UL44 and UL45, the region located between UL45 and UL46, the region located between US10 and SORF3, and the region located between SORF3 and US2.

Claim (Index 8):
A multivalent vaccine which comprises an effective immunizing amount of recombinant avian herpes virus of  claim 1 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.76596
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14388268', '15972283', '14915534', '13655858', '14682798']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8248757738937009
- 35 USC 102 Novelty (BERT): 0.6908981866682432
- Combined Prediction Score: 0.8114780151711551
- Mean Citation Score: 587.05412
- Max Citation Score: 856.81714
- Similarity Product: 684.4759816791964

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test